JP2024536358A5 - - Google Patents
Info
- Publication number
- JP2024536358A5 JP2024536358A5 JP2024520682A JP2024520682A JP2024536358A5 JP 2024536358 A5 JP2024536358 A5 JP 2024536358A5 JP 2024520682 A JP2024520682 A JP 2024520682A JP 2024520682 A JP2024520682 A JP 2024520682A JP 2024536358 A5 JP2024536358 A5 JP 2024536358A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- light chain
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110881474 | 2021-08-02 | ||
| CN202110881474.1 | 2021-08-02 | ||
| PCT/CN2022/108881 WO2023011338A1 (zh) | 2021-08-02 | 2022-07-29 | 抗CD79b×CD3双特异性抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536358A JP2024536358A (ja) | 2024-10-04 |
| JP2024536358A5 true JP2024536358A5 (https=) | 2025-08-06 |
Family
ID=85154284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520682A Pending JP2024536358A (ja) | 2021-08-02 | 2022-07-29 | 抗ｃｄ７９ｂ×ｃｄ３二重特異性抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240343799A1 (https=) |
| EP (1) | EP4382538A4 (https=) |
| JP (1) | JP2024536358A (https=) |
| CN (1) | CN117897404A (https=) |
| AU (1) | AU2022324406A1 (https=) |
| CA (1) | CA3231174A1 (https=) |
| WO (1) | WO2023011338A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118667023B (zh) * | 2024-07-16 | 2025-07-15 | 上海生物制品研究所有限责任公司 | 一种抗ox40抗体及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| AU691811B2 (en) | 1993-06-16 | 1998-05-28 | Celltech Therapeutics Limited | Antibodies |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| ATE375365T1 (de) | 1998-04-02 | 2007-10-15 | Genentech Inc | Antikörper varianten und fragmente davon |
| PL209392B1 (pl) | 1999-01-15 | 2011-08-31 | Genentech Inc | Przeciwciało, komórka gospodarza, sposób wytwarzania przeciwciała oraz zastosowanie przeciwciała |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| TWI335821B (en) | 2002-12-16 | 2011-01-11 | Genentech Inc | Immunoglobulin variants and uses thereof |
| DK1791565T3 (en) | 2004-09-23 | 2016-08-01 | Genentech Inc | Cysteingensplejsede antibodies and conjugates |
| ES2744540T3 (es) * | 2014-12-05 | 2020-02-25 | Hoffmann La Roche | Anticuerpos anti-CD79b y procedimientos de uso |
| CA3021634A1 (en) * | 2016-04-15 | 2017-10-19 | Zymeworks Inc. | Multi-specific antigen-binding constructs targeting immunotherapeutics |
| WO2017214096A1 (en) * | 2016-06-07 | 2017-12-14 | Macrogenics, Inc. | Methods for the use of cd32b x cd79b-binding molecules in the treatment of inflammatory diseases and disorders |
| CN113194966A (zh) * | 2018-10-03 | 2021-07-30 | 柰裴斯生命科学公司 | 抗cd79抗体及其应用 |
| TWI841790B (zh) * | 2019-09-30 | 2024-05-11 | 大陸商和鉑醫藥（上海）有限責任公司 | 靶向cd3的抗體、雙特異性抗體及其用途 |
| JP2023543826A (ja) * | 2020-09-29 | 2023-10-18 | イノベント バイオロジクス（シンガポール）プライベート リミティド | 抗ｃｄ３抗体およびその使用 |
-
2022
- 2022-07-29 CN CN202280053838.XA patent/CN117897404A/zh active Pending
- 2022-07-29 CA CA3231174A patent/CA3231174A1/en active Pending
- 2022-07-29 WO PCT/CN2022/108881 patent/WO2023011338A1/zh not_active Ceased
- 2022-07-29 EP EP22852051.6A patent/EP4382538A4/en active Pending
- 2022-07-29 US US18/294,212 patent/US20240343799A1/en active Pending
- 2022-07-29 AU AU2022324406A patent/AU2022324406A1/en active Pending
- 2022-07-29 JP JP2024520682A patent/JP2024536358A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024109678A5 (https=) | ||
| JP2023075294A (ja) | 抗ｃｄ４７抗体及びその応用 | |
| JP2024522360A5 (https=) | ||
| JP2021533726A5 (https=) | ||
| JP2021516974A5 (https=) | ||
| JP2021515565A5 (https=) | ||
| CN112135626A (zh) | 抗tigit抗体及其用途 | |
| JP2021526022A5 (https=) | ||
| CN112969476B (zh) | 多特异性蛋白分子 | |
| JP2019527553A5 (https=) | ||
| JP2020522280A5 (https=) | ||
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| CN112955471A (zh) | Cd3抗体及其药物用途 | |
| JP2022533538A5 (https=) | ||
| JP2025067915A5 (https=) | ||
| JP2020522281A5 (https=) | ||
| CN114502591A (zh) | 靶向bcma的抗体、双特异性抗体及其用途 | |
| RU2015142815A (ru) | Лечение рака с использованием антител, связывающихся с поверхностным grp78 | |
| JP2021500916A5 (https=) | ||
| CN112513094A (zh) | 结合人her2的抗体、其制备方法和用途 | |
| JP2023540526A5 (https=) | ||
| JP2024540148A5 (https=) | ||
| JP2017521054A5 (https=) | ||
| JP2023543826A5 (https=) | ||
| JP2024500512A5 (https=) |